Good MorningEquity markets advanced in the week ended 9/1, but additional upside may be limited. The move was driven by softening labor market data that led the market to reprice its expectation for interest rates. Softer labor market data is good news, but the takeaway is that labor markets are normalizing at levels once considered strong. In this light, the data gives the FOMC little room to maneuver and may lead them to hike rates given the state of wage inflation. Wage inflation continues to run hot above 4.0%.
A new risk has emerged for the market and the Fed. The oil price rose to a new 1-year high this week, and looks like it will move significantly higher. Oil prices underpin inflation and cause it to remain hot if not accelerate. In this scenario, the FOMC should be expected to hike rates again this year, and they may do it more than once. Regarding the S&P 500, it is trading against critical resistance now. If the market can not move higher over the next few weeks, a 5% to 10% correction is likely. Featured: The A.I. Trend Has These 7 Stocks Set To Soar (Darwin) 
|
Markets | | | The automotive industry tends to be a very saturated place for consumers, with endless choices of brands and models; spoiled for choice, they can balance their selection between their needs. Today, investors face a similar dynamic when choosing the right automotive stock to buy potentially. However,... Read the Full Story |
|
From Our Partners?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>> | | | | Get the name of the stock here |
|
Stocks | | |
The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with upcoming catalysts to watch. These 2 stocks have been under the radar and surprised with exceptional earnings blowouts that exceeded EPS ... Read the Full Story |
|
Stocks | | |
It’s that time of year. Students are returning to classes again. NFL season is kicking off again. This means demand rises again for transportation. After a three-year hiatus, student loan repayments with interest resume. Football season starts again, which means wagering on games with more b... Read the Full Story |
|
From Our PartnersThe internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy. | | | | Here's the #1 stock to buy. |
|
Stocks | | |
Major pharmaceutical companies including Johnson & Johnson (NYSE: JNJ), Novartis AG (NYSE: NVS), Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. (NYSE: MRK), Eli Lilly & Co. (NYSE: LLY) and Amgen Inc. (NASDAQ: AMGN) were trading normally following... Read the Full Story |
|
Stocks | | | A choppy day of trading on Wall Street ended Friday with slight gains for stocks, as the market notched its second straight winning week.The market got a boost early on from a closely watched government report that showed U.S. job growth increased at a healthy, but more moderate pace last month. The... Read the Full Story |
|
From Our PartnersHe found Apple at $1.49… Oracle at $0.51… Amazon at $46.
Marketwatch called him "The Advisor Who Recommended Google Before Anyone Else."
Now, investing legend Louis Navellier is revealing his top 3 AI stocks to buy now. | | Click here to download your free copy. |
|
Markets | | | Stocks were higher in Europe and Asia on Monday following a report that signaled the US jobs market, while still healthy, shows some signs of cooling, raising hopes for an easing of interest rate hikes. Germany's DAX advanced 0.7% to 15,949.69 and the CAC 40 in Paris picked up 0.8% to 7,354.96. In L... Read the Full Story |
|
Markets | | | America's employers added 187,000 jobs in August, evidence of a slowing but still-resilient labor market despite the high interest rates the Federal Reserve has imposed. Last month's job growth marked an increase from July's revised gain of 157,000 but still pointed to a moderating pace of hiring co... Read the Full Story |
|
Markets | | | The average long-term U.S. mortgage rate declined this week after climbing five consecutive weeks to a more than 20-year high, a modest relief for would-be homebuyers challenged by rising home prices and a thin inventory of homes on the market Read the Full Story |
|
Markets | | |
AI is hot, and NVIDIA (NASDAQ: NVDA) is getting most of the spotlight. While the market is focused on its dominating position with GPUs, data centers, and generative AI, companies like MongoDB (NASDAQ: MDB) quietly perform equally well. MongoDB, Inc.'s Q1 results were an early indication of the co... Read the Full Story |
|
Markets | | | Oprah Winfrey and Dwayne Johnson have committed $10 million to make direct payments to people on Maui who are unable to return to their homes because of the wildfires, through a new fund they announced Thursday.The People's Fund of Maui will give $1,200 a month to adults who are not able to return t... Read the Full Story |
|
Monday's Early Bird Stock Of The Day International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY. | | View Today's Stock Pick |
|
